| 1. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 2. | | Recruiting | Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 3. | | Recruiting | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
Conditions: Endocrine Cancer; female reproductive cancer; neurotoxicity |
| 4. | | Completed | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Conditions: Endometrial Cancer; ovarian epithelial cancer; Cervical Cancer; uterine sarcoma |
| 5. | | No longer recruiting | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 6. | | Recruiting | Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 7. | | No longer recruiting | Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 8. | | Suspended | BMS-247550 in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 9. | | Recruiting | Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 10. | | Suspended | Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Conditions: stage III cervical cancer; recurrent cervical cancer; stage IVB cervical cancer; stage IVA cervical cancer; cervical squamous cell carcinoma |
| 11. | | Recruiting | Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma |
| 12. | | No longer recruiting | Capecitabine in Treating Women With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 13. | | Recruiting | Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 14. | | Recruiting | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
Condition: ovarian epithelial cancer |
| 15. | | Not yet recruiting | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer; high-grade squamous intraepithelial lesion |
| 16. | | Recruiting | Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 17. | | Completed | Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage IB cervical cancer |
| 18. | | No longer recruiting | Chemotherapy in Treating Patients With Sarcoma of the Uterus
Conditions: uterine leiomyosarcoma; recurrent uterine sarcoma; uterine carcinosarcoma; stage IV uterine sarcoma; Endometrial Stromal Sarcoma |
| 19. | | Completed | Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer
Conditions: ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ... |
| 20. | | Not yet recruiting | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
Conditions: squamous cell carcinoma of the vulva; stage III vulvar cancer; stage IV vulvar cancer |
| 21. | | Suspended | Combination Chemotherapy and Filgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Conditions: recurrent uterine sarcoma; uterine leiomyosarcoma |
| 22. | | Completed | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
Conditions: ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ... |
| 23. | | No longer recruiting | Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer |
| 24. | | No longer recruiting | Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; stage I ovarian epithelial cancer; ... |
| 25. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
Conditions: peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 26. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
Conditions: ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; recurrent ovarian epithelial cancer; ... |
| 27. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
Conditions: recurrent uterine sarcoma; stage III uterine sarcoma; stage IV uterine sarcoma |
| 28. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 29. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 30. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: ovarian serous cystadenocarcinoma; ovarian endometrioid adenocarcinoma; peritoneal cavity cancer; ovarian mixed epithelial carcinoma; ... |
| 31. | | Recruiting | Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
| 32. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 33. | | Suspended | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma; ... |
| 34. | | Recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; stage IV endometrial cancer; endometrial papillary carcinoma; endometrial clear cell carcinoma |
| 35. | | Suspended | Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
Conditions: stage IV uterine sarcoma; recurrent uterine sarcoma; uterine leiomyosarcoma |
| 36. | | No longer recruiting | Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Conditions: stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer |
| 37. | | No longer recruiting | Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer
Conditions: ovarian serous cystadenocarcinoma; stage III ovarian epithelial cancer; ovarian clear cell cystadenocarcinoma; ovarian endometrioid adenocarcinoma; ... |
| 38. | | Recruiting | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; recurrent cervical cancer; ... |
| 39. | | No longer recruiting | Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients with Stage I or Stage II Endometrial Cancer
Condition: Endometrial Cancer |
| 40. | | No longer recruiting | Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: recurrent cervical cancer; stage IVB cervical cancer; cervical squamous cell carcinoma; cervical adenocarcinoma; ... |
| 41. | | No longer recruiting | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: stage III endometrial cancer; endometrial adenocarcinoma; endometrial adenosquamous cell carcinoma; endometrial adenoacanthoma; ... |
| 42. | | Suspended | CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: peritoneal cavity cancer; recurrent ovarian epithelial cancer |
| 43. | | No longer recruiting | Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
Conditions: recurrent gestational trophoblastic tumor; nonmetastatic gestational trophoblastic tumor; good prognosis metastatic gestational trophoblastic tumor |
| 44. | | Completed | Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Conditions: stage IV endometrial cancer; recurrent endometrial cancer |
| 45. | | Recruiting | Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 46. | | Recruiting | Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
Conditions: recurrent endometrial cancer; stage III endometrial cancer; stage IV endometrial cancer |
| 47. | | Completed | Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer |
| 48. | | Recruiting | EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
Conditions: cervical adenocarcinoma; cervical adenosquamous cell carcinoma; cervical squamous cell carcinoma; stage IIB cervical cancer; ... |
| 49. | | Recruiting | Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Conditions: recurrent cervical cancer; cervical squamous cell carcinoma |
| 50. | | No longer recruiting | Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
Conditions: stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma |
